is based on real changes in your body, not symptoms alone
As a result, researchers are exploring whether gastric motility changes remain stable during long-term therapy or gradually diminish
However, this solution may not last long
Lien S, Larsson AK, Mannervik B
BPC-157 is unusually stable in human gastric juice for a peptide, which is why oral and capsule formats appear in research planning, especially for gut models
Contacts Media Contact Jessica Cotrone, Head of Corporate Communications [email protected], 978.760.5622 Investor Contact Brian Luque, Head of Investor Relations and Corporate Development [email protected], 951.206.1200 An infographic accompanying this announcement is available at